China SXT Pharmaceuticals, Inc. - SXTC
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Invesco Ltd. | History | New | 89,660 | 140 | 0.0% | — | 1 | +89,660 | New | Q3 2025 | Nov 13, 2025 |
| GEODE CAPITAL MANAGEMENT, LLC | History | New | 53,671 | 85 | 0.0% | — | 2 | +53,671 | New | Q3 2025 | Nov 12, 2025 |
| CITADEL ADVISORS LLC | History | New | 48,759 | 77 | 0.0% | — | 3 | +48,759 | New | Q3 2025 | Nov 14, 2025 |
| RENAISSANCE TECHNOLOGIES LLC | History | New | 44,500 | 69 | 0.0% | — | 4 | +44,500 | New | Q3 2025 | Nov 13, 2025 |
| Virtu Financial LLC | History | Added to | 28,983 | 46 | 0.0% | 0.0% | 5 | +15,013 | 107.47% | Q3 2025 | Nov 14, 2025 |
| HRT FINANCIAL LP | History | New | 26,749 | 42 | 0.0% | — | 6 | +26,749 | New | Q3 2025 | Nov 14, 2025 |
| TWO SIGMA SECURITIES, LLC | History | New | 15,449 | 24 | 0.0% | — | 7 | +15,449 | New | Q3 2025 | Nov 14, 2025 |
| Tower Research Capital LLC (TRC) | History | Added to | 2,878 | 4 | 0.0% | — | 8 | +2,727 | 1805.96% | Q3 2025 | Nov 14, 2025 |
| UBS Group AG | History | Reduced | 100 | 0 | — | 0.0% | — | -62,499 | -99.84% | Q3 2025 | Nov 13, 2025 |
| State of Wyoming | History | New | 89 | 0 | — | — | — | +89 | New | Q3 2025 | Nov 04, 2025 |
| ACADIAN ASSET MANAGEMENT LLC | History | Closed out | 0 | 0 | — | — | — | -48 | -100.0% | Q3 2025 | Nov 13, 2025 |